Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acromegaly × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 58 Breast Neoplasms 45 Myelodysplastic Syndromes 25 Neoplasms 23 Advanced Solid Tumor 22 Carcinoma, Non-Small-Cell Lung 21 Advanced Solid Tumors 20 Prostatic Neoplasms 19 Stomach Neoplasms 16 Recurrence 16 Neoplasm Metastasis 15 Carcinoma, Hepatocellular 15 Multiple Myeloma 14 Leukemia, Myelomonocytic, Chronic 13 Pancreatic Neoplasms 12 Lung Neoplasms 12 Solid Tumor 11 Ovarian Neoplasms 11 Uterine Cervical Neoplasms 10 Melanoma 10 Lymphoma, Large B-Cell, Diffuse 10 Sarcoma 9 Myeloproliferative Disorders 8 Colorectal Neoplasms 8 Small Cell Lung Carcinoma 7 Lymphoma, B-Cell 7 Esophageal Neoplasms 7 Biliary Tract Neoplasms 7 Carcinoma, Transitional Cell 6 Triple Negative Breast Neoplasms 5

Interventions

lanreotide 3 Octreotide 3 pegvisomant 2 pasireotide 2 Cabergoline 2 Transcranial Magnetic Stimulation 1 Tissue Banks 1 Surgical Procedures, Operative 1 Solutions 1 Radiosurgery 1 Observation 1 Injections 1 Dosage Forms 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03439709 2018-03-01

MERGE

Samsung Medical Center

Phase 3 Unknown

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡